These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 8789977)

  • 1. Comparison of adverse events associated with use of mefloquine and combination of chloroquine and proguanil as antimalarial prophylaxis: postal and telephone survey of travellers.
    Barrett PJ; Emmins PD; Clarke PD; Bradley DJ
    BMJ; 1996 Aug; 313(7056):525-8. PubMed ID: 8789977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reported side effects to chloroquine, chloroquine plus proguanil, and mefloquine as chemoprophylaxis against malaria in Danish travelers.
    Petersen E; Ronne T; Ronn A; Bygbjerg I; Larsen SO
    J Travel Med; 2000; 7(2):79-84. PubMed ID: 10759574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adverse effects and compliance with mefloquine or proguanil antimalarial chemoprophylaxis.
    Hoebe C; de Munter J; Thijs C
    Eur J Clin Pharmacol; 1997; 52(4):269-75. PubMed ID: 9248763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mefloquine for preventing malaria during travel to endemic areas.
    Tickell-Painter M; Maayan N; Saunders R; Pace C; Sinclair D
    Cochrane Database Syst Rev; 2017 Oct; 10(10):CD006491. PubMed ID: 29083100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drugs for preventing malaria in travellers.
    Jacquerioz FA; Croft AM
    Cochrane Database Syst Rev; 2009 Oct; (4):CD006491. PubMed ID: 19821371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Compliance and tolerability of mefloquine and chloroquine plus proguanil for long-term malaria chemoprophylaxis in groups at particular risk (the military).
    Peragallo MS; Sabatinelli G; Sarnicola G
    Trans R Soc Trop Med Hyg; 1999; 93(1):73-7. PubMed ID: 10492796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Compliance with and tolerance of mefloquine and chloroquine + proguanil malaria chemoprophylaxis in French short-term travellers to sub-Saharan Africa.
    Carme B; Peguet C; Nevez G
    Trop Med Int Health; 1997 Oct; 2(10):953-6. PubMed ID: 9357484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Adverse effects associated with antimalarial chemoprophylaxis].
    Corominas N; Gascón J; Mejías T; Caparrós F; Quintó L; Codina C; Ribas J; Corachán M
    Med Clin (Barc); 1997 May; 108(20):772-5. PubMed ID: 9265081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Side effects of and compliance with malaria prophylaxis in children.
    Albright TA; Binns HJ; Katz BZ
    J Travel Med; 2002; 9(6):289-92. PubMed ID: 12962582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Many travellers suffer of side-effects of malaria prophylaxis].
    Rietz G; Petersson H; Odenholt I
    Lakartidningen; 2002 Jun; 99(26-27):2939-44. PubMed ID: 12170684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative benefit of malaria chemoprophylaxis modelled in United Kingdom travellers.
    Toovey S; Nieforth K; Smith P; Schlagenhauf P; Adamcova M; Tatt I; Tomianovic D; Schnetzler G
    Travel Med Infect Dis; 2014; 12(6 Pt B):726-32. PubMed ID: 25443997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adverse events associated with mefloquine. Study in returned travellers confirms authors' findings.
    Corbett EL; Doherty JP; Behrens RH
    BMJ; 1996 Dec; 313(7071):1552. PubMed ID: 8978255
    [No Abstract]   [Full Text] [Related]  

  • 13. [Malaria chemoprophylaxis: tolerance and compliance with mefloquine and proguanil/chloroquine combination in French tourists].
    Carme B; Péguet C; Nevez G
    Bull Soc Pathol Exot; 1997; 90(4):273-6. PubMed ID: 9479468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mefloquine compared with other malaria chemoprophylactic regimens in tourists visiting east Africa.
    Steffen R; Fuchs E; Schildknecht J; Naef U; Funk M; Schlagenhauf P; Phillips-Howard P; Nevill C; Stürchler D
    Lancet; 1993 May; 341(8856):1299-303. PubMed ID: 8098447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tolerability of malaria chemoprophylaxis in non-immune travellers to sub-Saharan Africa: multicentre, randomised, double blind, four arm study.
    Schlagenhauf P; Tschopp A; Johnson R; Nothdurft HD; Beck B; Schwartz E; Herold M; Krebs B; Veit O; Allwinn R; Steffen R
    BMJ; 2003 Nov; 327(7423):1078. PubMed ID: 14604928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atovaquone/proguanil: a review of its use for the prophylaxis of Plasmodium falciparum malaria.
    McKeage K; Scott L
    Drugs; 2003; 63(6):597-623. PubMed ID: 12656656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Not more symptoms with mefloquine use than with other drugs in malaria prophylaxis].
    Wolters BA; Bosje T; Luinstra-Passchier MJ
    Ned Tijdschr Geneeskd; 1997 Feb; 141(7):331-4. PubMed ID: 9132607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Side effects of mefloquine prophylaxis for malaria: an independent randomized controlled trial.
    Croft AM; Clayton TC; World MJ
    Trans R Soc Trop Med Hyg; 1997; 91(2):199-203. PubMed ID: 9196769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term malaria prophylaxis with weekly mefloquine.
    Lobel HO; Miani M; Eng T; Bernard KW; Hightower AW; Campbell CC
    Lancet; 1993 Apr; 341(8849):848-51. PubMed ID: 8096560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The efficacy of chemoprophylaxis against malaria with chloroquine plus proguanil, mefloquine, and atovaquone plus proguanil in travelers from Denmark.
    Kofoed K; Petersen E
    J Travel Med; 2003; 10(3):150-4. PubMed ID: 12757688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.